Global Recombinant Non-Glycosylated Proteins Biosimilars Market Research Report 2019

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 94

Report ID: 24475

Recombinant non-glycosylated proteins include human growth hormone, granulocyte colony-stimulating factor, interferons, and insulin. The statistic scope in this report is Recombinant non-glycosylated proteins biosimilars.

The global Recombinant Non-Glycosylated Proteins Biosimilars market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Recombinant Non-Glycosylated Proteins Biosimilars volume and value at global level, regional level and company level. From a global perspective, this report represents overall Recombinant Non-Glycosylated Proteins Biosimilars market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Sandoz
Pfizer
Teva Pahrmaceutical
Celltrion
Biocon
Amgen
Samsung Biologics
Mylan
Dr. Reddy's Laboratories
Stada Arzneimittel AG

Segment by Regions
North America
Europe
China
Japan

Segment by Type
Insulin
rHGH
Interferon

Segment by Application
Oncology
Chronic Diseases
Autoimmune Diseases
Blood Disorders
Growth Hormone Deficiency
Infectious Diseases
Other Diseases

Table of Contents

Executive Summary
1 Recombinant Non-Glycosylated Proteins Biosimilars Market Overview
1.1 Product Overview and Scope of Recombinant Non-Glycosylated Proteins Biosimilars
1.2 Recombinant Non-Glycosylated Proteins Biosimilars Segment by Type
1.2.1 Global Recombinant Non-Glycosylated Proteins Biosimilars Production Growth Rate Comparison by Type (2014-2025)
1.2.2 Insulin
1.2.3 rHGH
1.2.4 Interferon
1.3 Recombinant Non-Glycosylated Proteins Biosimilars Segment by Application
1.3.1 Recombinant Non-Glycosylated Proteins Biosimilars Consumption Comparison by Application (2014-2025)
1.3.2 Oncology
1.3.3 Chronic Diseases
1.3.4 Autoimmune Diseases
1.3.5 Blood Disorders
1.3.6 Growth Hormone Deficiency
1.3.7 Infectious Diseases
1.3.8 Other Diseases
1.4 Global Recombinant Non-Glycosylated Proteins Biosimilars Market by Region
1.4.1 Global Recombinant Non-Glycosylated Proteins Biosimilars Market Size Region
1.4.2 North America Status and Prospect (2014-2025)
1.4.3 Europe Status and Prospect (2014-2025)
1.4.4 China Status and Prospect (2014-2025)
1.4.5 Japan Status and Prospect (2014-2025)
1.5 Global Recombinant Non-Glycosylated Proteins Biosimilars Market Size
1.5.1 Global Recombinant Non-Glycosylated Proteins Biosimilars Revenue (2014-2025)
1.5.2 Global Recombinant Non-Glycosylated Proteins Biosimilars Production (2014-2025)

2 Global Recombinant Non-Glycosylated Proteins Biosimilars Market Competition by Manufacturers
2.1 Global Recombinant Non-Glycosylated Proteins Biosimilars Production Market Share by Manufacturers (2014-2019)
2.2 Global Recombinant Non-Glycosylated Proteins Biosimilars Revenue Share by Manufacturers (2014-2019)
2.3 Global Recombinant Non-Glycosylated Proteins Biosimilars Average Price by Manufacturers (2014-2019)
2.4 Manufacturers Recombinant Non-Glycosylated Proteins Biosimilars Production Sites, Area Served, Product Types
2.5 Recombinant Non-Glycosylated Proteins Biosimilars Market Competitive Situation and Trends
2.5.1 Recombinant Non-Glycosylated Proteins Biosimilars Market Concentration Rate
2.5.2 Recombinant Non-Glycosylated Proteins Biosimilars Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

3 Global Recombinant Non-Glycosylated Proteins Biosimilars Production Market Share by Regions
3.1 Global Recombinant Non-Glycosylated Proteins Biosimilars Production Market Share by Regions
3.2 Global Recombinant Non-Glycosylated Proteins Biosimilars Revenue Market Share by Regions (2014-2019)
3.3 Global Recombinant Non-Glycosylated Proteins Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
3.4 North America Recombinant Non-Glycosylated Proteins Biosimilars Production
3.4.1 North America Recombinant Non-Glycosylated Proteins Biosimilars Production Growth Rate (2014-2019)
3.4.2 North America Recombinant Non-Glycosylated Proteins Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
3.5 Europe Recombinant Non-Glycosylated Proteins Biosimilars Production
3.5.1 Europe Recombinant Non-Glycosylated Proteins Biosimilars Production Growth Rate (2014-2019)
3.5.2 Europe Recombinant Non-Glycosylated Proteins Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
3.6 China Recombinant Non-Glycosylated Proteins Biosimilars Production (2014-2019)
3.6.1 China Recombinant Non-Glycosylated Proteins Biosimilars Production Growth Rate (2014-2019)
3.6.2 China Recombinant Non-Glycosylated Proteins Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
3.7 Japan Recombinant Non-Glycosylated Proteins Biosimilars Production (2014-2019)
3.7.1 Japan Recombinant Non-Glycosylated Proteins Biosimilars Production Growth Rate (2014-2019)
3.7.2 Japan Recombinant Non-Glycosylated Proteins Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Recombinant Non-Glycosylated Proteins Biosimilars Consumption by Regions
4.1 Global Recombinant Non-Glycosylated Proteins Biosimilars Consumption by Regions
4.2 North America Recombinant Non-Glycosylated Proteins Biosimilars Consumption (2014-2019)
4.3 Europe Recombinant Non-Glycosylated Proteins Biosimilars Consumption (2014-2019)
4.4 China Recombinant Non-Glycosylated Proteins Biosimilars Consumption (2014-2019)
4.5 Japan Recombinant Non-Glycosylated Proteins Biosimilars Consumption (2014-2019)

5 Global Recombinant Non-Glycosylated Proteins Biosimilars Production, Revenue, Price Trend by Type
5.1 Global Recombinant Non-Glycosylated Proteins Biosimilars Production Market Share by Type (2014-2019)
5.2 Global Recombinant Non-Glycosylated Proteins Biosimilars Revenue Market Share by Type (2014-2019)
5.3 Global Recombinant Non-Glycosylated Proteins Biosimilars Price by Type (2014-2019)
5.4 Global Recombinant Non-Glycosylated Proteins Biosimilars Production Growth by Type (2014-2019)

6 Global Recombinant Non-Glycosylated Proteins Biosimilars Market Analysis by Applications
6.1 Global Recombinant Non-Glycosylated Proteins Biosimilars Consumption Market Share by Application (2014-2019)
6.2 Global Recombinant Non-Glycosylated Proteins Biosimilars Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Recombinant Non-Glycosylated Proteins Biosimilars Business
7.1 Sandoz
7.1.1 Sandoz Recombinant Non-Glycosylated Proteins Biosimilars Production Sites and Area Served
7.1.2 Recombinant Non-Glycosylated Proteins Biosimilars Product Introduction, Application and Specification
7.1.3 Sandoz Recombinant Non-Glycosylated Proteins Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
7.1.4 Main Business and Markets Served
7.2 Pfizer
7.2.1 Pfizer Recombinant Non-Glycosylated Proteins Biosimilars Production Sites and Area Served
7.2.2 Recombinant Non-Glycosylated Proteins Biosimilars Product Introduction, Application and Specification
7.2.3 Pfizer Recombinant Non-Glycosylated Proteins Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
7.2.4 Main Business and Markets Served
7.3 Teva Pahrmaceutical
7.3.1 Teva Pahrmaceutical Recombinant Non-Glycosylated Proteins Biosimilars Production Sites and Area Served
7.3.2 Recombinant Non-Glycosylated Proteins Biosimilars Product Introduction, Application and Specification
7.3.3 Teva Pahrmaceutical Recombinant Non-Glycosylated Proteins Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
7.3.4 Main Business and Markets Served
7.4 Celltrion
7.4.1 Celltrion Recombinant Non-Glycosylated Proteins Biosimilars Production Sites and Area Served
7.4.2 Recombinant Non-Glycosylated Proteins Biosimilars Product Introduction, Application and Specification
7.4.3 Celltrion Recombinant Non-Glycosylated Proteins Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
7.4.4 Main Business and Markets Served
7.5 Biocon
7.5.1 Biocon Recombinant Non-Glycosylated Proteins Biosimilars Production Sites and Area Served
7.5.2 Recombinant Non-Glycosylated Proteins Biosimilars Product Introduction, Application and Specification
7.5.3 Biocon Recombinant Non-Glycosylated Proteins Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
7.5.4 Main Business and Markets Served
7.6 Amgen
7.6.1 Amgen Recombinant Non-Glycosylated Proteins Biosimilars Production Sites and Area Served
7.6.2 Recombinant Non-Glycosylated Proteins Biosimilars Product Introduction, Application and Specification
7.6.3 Amgen Recombinant Non-Glycosylated Proteins Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
7.6.4 Main Business and Markets Served
7.7 Samsung Biologics
7.7.1 Samsung Biologics Recombinant Non-Glycosylated Proteins Biosimilars Production Sites and Area Served
7.7.2 Recombinant Non-Glycosylated Proteins Biosimilars Product Introduction, Application and Specification
7.7.3 Samsung Biologics Recombinant Non-Glycosylated Proteins Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
7.7.4 Main Business and Markets Served
7.8 Mylan
7.8.1 Mylan Recombinant Non-Glycosylated Proteins Biosimilars Production Sites and Area Served
7.8.2 Recombinant Non-Glycosylated Proteins Biosimilars Product Introduction, Application and Specification
7.8.3 Mylan Recombinant Non-Glycosylated Proteins Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
7.8.4 Main Business and Markets Served
7.9 Dr. Reddy's Laboratories
7.9.1 Dr. Reddy's Laboratories Recombinant Non-Glycosylated Proteins Biosimilars Production Sites and Area Served
7.9.2 Recombinant Non-Glycosylated Proteins Biosimilars Product Introduction, Application and Specification
7.9.3 Dr. Reddy's Laboratories Recombinant Non-Glycosylated Proteins Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
7.9.4 Main Business and Markets Served
7.10 Stada Arzneimittel AG
7.10.1 Stada Arzneimittel AG Recombinant Non-Glycosylated Proteins Biosimilars Production Sites and Area Served
7.10.2 Recombinant Non-Glycosylated Proteins Biosimilars Product Introduction, Application and Specification
7.10.3 Stada Arzneimittel AG Recombinant Non-Glycosylated Proteins Biosimilars Production, Revenue, Price and Gross Margin (2014-2019)
7.10.4 Main Business and Markets Served

8 Recombinant Non-Glycosylated Proteins Biosimilars Manufacturing Cost Analysis
8.1 Recombinant Non-Glycosylated Proteins Biosimilars Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Recombinant Non-Glycosylated Proteins Biosimilars
8.4 Recombinant Non-Glycosylated Proteins Biosimilars Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.2 Recombinant Non-Glycosylated Proteins Biosimilars Distributors List
9.3 Recombinant Non-Glycosylated Proteins Biosimilars Customers

10 Market Dynamics
10.1 Market Trends
10.2 Opportunities
10.3 Market Drivers
10.4 Challenges
10.5 Influence Factors

11 Global Recombinant Non-Glycosylated Proteins Biosimilars Market Forecast
11.1 Global Recombinant Non-Glycosylated Proteins Biosimilars Production, Revenue Forecast
11.1.1 Global Recombinant Non-Glycosylated Proteins Biosimilars Production Growth Rate Forecast (2019-2025)
11.1.2 Global Recombinant Non-Glycosylated Proteins Biosimilars Revenue and Growth Rate Forecast (2019-2025)
11.1.3 Global Recombinant Non-Glycosylated Proteins Biosimilars Price and Trend Forecast (2019-2025)
11.2 Global Recombinant Non-Glycosylated Proteins Biosimilars Production Forecast by Regions (2019-2025)
11.2.1 North America Recombinant Non-Glycosylated Proteins Biosimilars Production, Revenue Forecast (2019-2025)
11.2.2 Europe Recombinant Non-Glycosylated Proteins Biosimilars Production, Revenue Forecast (2019-2025)
11.2.3 China Recombinant Non-Glycosylated Proteins Biosimilars Production, Revenue Forecast (2019-2025)
11.2.4 Japan Recombinant Non-Glycosylated Proteins Biosimilars Production, Revenue Forecast (2019-2025)
11.3 Global Recombinant Non-Glycosylated Proteins Biosimilars Consumption Forecast by Regions (2019-2025)
11.3.1 North America Recombinant Non-Glycosylated Proteins Biosimilars Consumption Forecast (2019-2025)
11.3.2 Europe Recombinant Non-Glycosylated Proteins Biosimilars Consumption Forecast (2019-2025)
11.3.3 China Recombinant Non-Glycosylated Proteins Biosimilars Consumption Forecast (2019-2025)
11.3.4 Japan Recombinant Non-Glycosylated Proteins Biosimilars Consumption Forecast (2019-2025)
11.4 Global Recombinant Non-Glycosylated Proteins Biosimilars Production, Revenue and Price Forecast by Type (2019-2025)
11.5 Global Recombinant Non-Glycosylated Proteins Biosimilars Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer